Diomics
  • Initiatives
    • Diovaxx
    • Dioguard
    • Diabetes
  • News
  • Company

Latest News


Keep up with the latest news and updates from DIOMICS

Press Inquiries

For press inquires email [email protected]

__CONFIG_colors_palette__{"active_palette":0,"config":{"colors":{"62516":{"name":"Main Accent","parent":-1}},"gradients":[]},"palettes":[{"name":"Default Palette","value":{"colors":{"62516":{"val":"var(--tcb-skin-color-0)"}},"gradients":[]}}]}__CONFIG_colors_palette__
FAQs on Diocheck™
__CONFIG_colors_palette__{"active_palette":0,"config":{"colors":{"62516":{"name":"Main Accent","parent":-1}},"gradients":[]},"palettes":[{"name":"Default Palette","value":{"colors":{"62516":{"val":"var(--tcb-skin-color-0)"}},"gradients":[]}}]}__CONFIG_colors_palette__
FAQs on Dioguard™
March 29, 2021

Diomics Corporation and Bonne Santé Group Announce Strategic Alliance Agreement

March 25, 2021

Diomics Corporation Adds Industry Heavyweight, Former Amway Coo To Its Board Of Directors

October 5, 2020

A Human Antibody Nasal Spray Under Development Might Have Prevented White House Infections, Scientists At Diomics And Active Motif Say

September 16, 2020

Diomics Announces Agreement with Department of Defense to Accelerate Development and Testing of Diocheck™ SARS-CoV-2 Immune Response Indicator Patch

September 11, 2020

Diomics Aims to Nose Out Coronavirus Ahead of Vaccines With Nasal Spray That Delivers Monoclonal Antibody Protection

August 19, 2020

Diomics Announces Development Of Diocheck™ Visual Antibody Indicator

February 5, 2020

Diomics Corp. Announces Development of Intellectual Property and Patents Related to the Identification of Airborne Pathogens

January 2, 2020

Diomics Corporation and University of California, Irvine Collaborate to Enable Cell Therapy Clinical Trial for Type 1 Diabetes

Page [tcb_pagination_current_page] of [tcb_pagination_total_pages]

First

Previous

Next

Last

Copyright 2022 Diomics, Inc, all rights reserved. Privacy Policy